Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma

NCT04534322 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG: Melphalan Flufenamide
DRUG: Dexamethasone

Sponsor

Oncopeptides AB